Description:
Bionorica Canephron Coated Tablets 60

Detailed Description:
Proprietary name (and dosage form):Canephron® coated tablets.Composition:1 coated tablet contains:18 mg pulverized centaury, 18 mg pulverized lovage root, 18 mg pulverized rosemary leaves.List of excipients:Calcium carbonate, spray-dried glucose syrup, lactose monohydrate, magnesium stearate, maize starch and modified maize starch, montan glycol wax, povidone (K 25, 30), virgin castor oil, sucrose, shellac, colloidal anhydrous silica, talc, dyes: iron-(III)-oxide (E172), riboflavine (E101), titanium dioxide (E171).Pharmacological classification:A 32.16 other.Pharmacological action:Pharmacodynamic properties.No pharmacodynamic investigations were performed with Canephron® coated tablets. The plant components of Canephron® coated tablets have been shown to produce antibacterial, anti-inflammatory, spasmolytic and diuretic effects.Pharmacokinetic properties:No pharmacokinetic investigations were performed.Indications:For supportive treatment of urinary tract infections.Prevents the formation of kidney stones.Interactions:Interactions with other medicines are not known up to now.Identification:Canephron® coated tablets are orange coloured, round coated tablets.Presentation:Canephron® coated tablets are available as:Packages containing 60 coated tablets.Packages containing 120 coated tablets.Not all pack sizes may be marketed.1 coated tablet contains: pulverized centaury 18 mg pulverized lovage root 18 mg pulverized rosemary leaf 18 mg. Contains glucose, sucrose, lactose.Bionorica seal or origin.Under license from Bionorica SE 92308 Neumarkt Duitsland Germany.0860 AUSTELL/086028735, www.austell.co.za.For: Camox Pharmaceuticals (Pty) Ltd.

Pack size:
60 coated tablets

Quantity in pack:
60

Marketing description:
Bionorica®.Canephron®.For supportive treatment of urinary tract infections.Prevents the formation of kidney stones.60 coated tablets.Austell.

Brand:
Canephron

Package type:
Box